Charles River Laboratories to Participate in Upcoming Investor Conferences
Charles River Laboratories International, Inc. (NYSE: CRL) announced today that it will virtually present at two upcoming investor conferences, including:
- Jefferies London Healthcare Conference on Thursday, November 18th, with a pre-recording of the presentation available starting at 8:00 a.m. GMT (3:00 a.m. ET); and
- Evercore ISI 4th Annual HealthCONx Conference on Wednesday, December 1st, at 9:40 a.m. ET.
Management will present an overview of Charles River’s strategic focus and business developments.
A webcast of each presentation will be available through a link that will be posted on the Investor Relations section of the Charles River website at ir.criver.com. A webcast replay will be accessible through the same website after each event and will remain available for approximately two weeks.
About Charles River
Charles River provides essential products and services to help pharmaceutical and biotechnology companies, government agencies and leading academic institutions around the globe accelerate their research and drug development efforts. Our dedicated employees are focused on providing clients with exactly what they need to improve and expedite the discovery, early-stage development and safe manufacture of new therapies for the patients who need them. To learn more about our unique portfolio and breadth of services, visit www.criver.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20211116005084/en/
Charles River Labs Intl Stock
With 9 Buy predictions and not the single Sell prediction the community is currently very high on Charles River Labs Intl.
As a result the target price of 247 € shows a slightly positive potential of 16.34% compared to the current price of 212.3 € for Charles River Labs Intl.
